The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Extraordinary General Meeting (“EGM”) to be held on Friday 5 May 2023 at 10.00 a.m. at Good Morning Hotel, ... Read more
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH ... Read more
Stockholm, April 6, 2023 - Intervacc AB (publ) announces that the company's 2022 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is ... Read more
The period in summary
January 1 – December 31, 2022
- In the end of March the first batch of ... Read more
Stockholm, January 24, 2023 - Intervacc’s Chief Scientific Officer Dr Andrew Waller will talk about the prevention of equine strangles at the Federation of European Equine Veterinary Associations (FEEVA) European Horse ... Read more